BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29190918)

  • 1. Plasma lipid profiling and diagnostic biomarkers for oral squamous cell carcinoma.
    Wang L; Wang X; Li Y; Hou Y; Sun F; Zhou S; Li C; Zhang B
    Oncotarget; 2017 Nov; 8(54):92324-92332. PubMed ID: 29190918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of salivary metabolite biomarkers for early monitoring of oral cancer with ultra performance liquid chromatography-mass spectrometry.
    Wang Q; Gao P; Cheng F; Wang X; Duan Y
    Talanta; 2014 Feb; 119():299-305. PubMed ID: 24401418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid Identification of Biomarkers in Esophageal Squamous Cell Carcinoma by Lipidomic Analysis.
    Si T; Liu D; Li L; Xu Z; Jiang L; Zhai Y; Wu Q
    Nutr Cancer; 2024 May; ():1-11. PubMed ID: 38753560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of lipidomic platform and phosphatidylcholine retention time index for lipid profiling of rosuvastatin treated human plasma.
    Choi JM; Kim TE; Cho JY; Lee HJ; Jung BH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 944():157-65. PubMed ID: 24316528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma lipidomics reveal profound perturbation of glycerophospholipids, fatty acids, and sphingolipids in diet-induced hyperlipidemia.
    Miao H; Chen H; Pei S; Bai X; Vaziri ND; Zhao YY
    Chem Biol Interact; 2015 Feb; 228():79-87. PubMed ID: 25619641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultra-performance liquid chromatography-mass spectrometry as a sensitive and powerful technology in lipidomic applications.
    Zhao YY; Wu SP; Liu S; Zhang Y; Lin RC
    Chem Biol Interact; 2014 Sep; 220():181-92. PubMed ID: 25014415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid Fingerprinting of Different Material Sources by UPLC-Q-Exactive Orbitrap/MS Approach and Their Zebrafish-Based Activities Comparison.
    Li X; Li C; Zhu Y; Shi Y; Zhang X; Zhang S; Wang L; Lin H; Hou H; Hsiao CD; Han L; Liu K
    J Agric Food Chem; 2020 Feb; 68(7):2007-2015. PubMed ID: 31975591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation and identification of potential biomarkers in human saliva for the early diagnosis of oral squamous cell carcinoma.
    Wang Q; Gao P; Wang X; Duan Y
    Clin Chim Acta; 2014 Jan; 427():79-85. PubMed ID: 24144867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-Depth Lipidomic Analysis of Molecular Species of Triacylglycerides, Diacylglycerides, Glycerophospholipids, and Sphingolipids of Buttermilk by GC-MS/FID, HPLC-ELSD, and UPLC-QToF-MS.
    Castro-Gómez P; Montero O; Fontecha J
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential plasma lipid biomarkers in early-stage breast cancer.
    Jiang N; Zhang G; Pan L; Yan C; Zhang L; Weng Y; Wang W; Chen X; Yang G
    Biotechnol Lett; 2017 Nov; 39(11):1657-1666. PubMed ID: 28828718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.
    Grimm M; Hoefert S; Krimmel M; Biegner T; Feyen O; Teriete P; Reinert S
    Oral Maxillofac Surg; 2016 Sep; 20(3):295-302. PubMed ID: 26875085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A plasma lipidomics strategy reveals perturbed lipid metabolic pathways and potential lipid biomarkers of human colorectal cancer.
    Shen S; Yang L; Li L; Bai Y; Cai C; Liu H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():41-48. PubMed ID: 29028617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma.
    Wu CC; Chu HW; Hsu CW; Chang KP; Liu HP
    Proteomics; 2015 Oct; 15(19):3394-404. PubMed ID: 26205615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
    Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
    Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma metabolomics combined with lipidomics profiling reveals the potential antipyretic mechanisms of Qingkailing injection in a rat model.
    Qin L; Zhang Z; Guo M; Zhang Q; Wang Q; Lu Z; Zhao H; Liu Y; Fu S; Wang M; Gao X
    Chem Biol Interact; 2016 Jul; 254():24-33. PubMed ID: 27208622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary zinc finger protein 510 peptide as a novel biomarker for detection of oral squamous cell carcinoma in early stages.
    Jou YJ; Lin CD; Lai CH; Tang CH; Huang SH; Tsai MH; Chen SY; Kao JY; Lin CW
    Clin Chim Acta; 2011 Jul; 412(15-16):1357-65. PubMed ID: 21497587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of human plasma lipids and soybean lecithin by means of high-performance thin-layer chromatography and matrix-assisted laser desorption/ionization mass spectrometry.
    Stübiger G; Pittenauer E; Belgacem O; Rehulka P; Widhalm K; Allmaier G
    Rapid Commun Mass Spectrom; 2009 Sep; 23(17):2711-23. PubMed ID: 19639618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of glutathione S-transferase pi correlates with poorly differentiated grade in patients with oral squamous cell carcinoma.
    Ma HL; Yu C; Liu Y; Tan YR; Qiao JK; Yang X; Wang LZ; Li J; Chen Q; Chen FX; Zhang ZY; Zhong LP
    J Oral Pathol Med; 2015 Mar; 44(3):193-200. PubMed ID: 25047743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a truncated cystatin SA-I as a saliva biomarker for oral squamous cell carcinoma using the SELDI ProteinChip platform.
    Shintani S; Hamakawa H; Ueyama Y; Hatori M; Toyoshima T
    Int J Oral Maxillofac Surg; 2010 Jan; 39(1):68-74. PubMed ID: 19896329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased phosphatidylcholine plasmalogens--A putative novel lipid signature in patients with stable coronary artery disease and acute myocardial infarction.
    Sutter I; Klingenberg R; Othman A; Rohrer L; Landmesser U; Heg D; Rodondi N; Mach F; Windecker S; Matter CM; Lüscher TF; von Eckardstein A; Hornemann T
    Atherosclerosis; 2016 Mar; 246():130-40. PubMed ID: 26773473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.